Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Schizophrenia or Maintenance Monotherapy Treatment. Bipolar I Disorder
.
Show all posts
Showing posts with label
Schizophrenia or Maintenance Monotherapy Treatment. Bipolar I Disorder
.
Show all posts
Wednesday, February 14, 2024
FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults
›
In continuation of my update on aripiprazole Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announced ...
›
Home
View web version
